Abstract-Glycation of both protein and lipid components is believed to be involved in LDL oxidation. However, the relative importance of lipid and protein glycation in the oxidation process has not been established, and products of lipid glycation have not been isolated. Using glucosylated phosphatidylethanolamine (Glc PtdEtn) prepared synthetically, we have identified glycated diacyl and alkenylacyl species among the ethanolamine phospholipids in LDL. Accumulation of these glycation products in LDL incubated with glucose showed a time-and glucose concentration-dependent increase. LDL specifically enriched with Glc PtdEtn (25 nmol/mg protein) showed increased susceptibility to lipid oxidation when dialyzed against a 5-mol/L Cu 2ϩ solution. The presence of this glucosylated lipid resulted in a 5-fold increase in production of phospholipid-bound hydroperoxides and 4-fold increase in phospholipid-bound aldehydes. Inclusion of glucosylated phosphatidylethanolamine in the surface lipid monolayer of the LDL resulted in rapid loss of polyunsaturated cholesteryl esters from the interior of the particle during oxidation. Glycated ethanolamine phospholipids were also isolated and identified from atherosclerotic plaques collected from both diabetic and nondiabetic subjects. The present findings provide direct evidence for the previously proposed causative effect of lipid glycation on LDL oxidation. 
R ecent work on the pathogenesis of atherosclerosis implicates "oxidized" low density lipoprotein (LDL) as a key factor in the initiation of atherosclerotic lesions. 1 Research has suggested 2 that nonenzymatic glycation of apoprotein B and possibly aminophospholipids could promote generation of "oxidized" LDL. However, specific contributions of lipid and protein glycation to LDL oxidation have not been determined.
Nonenzymatic glycation is defined as a posttranslational modification of a protein by the covalent attachment of a sugar residue, which results in an amino-carbonyl bonding or a Schiff base linkage. The stable Amadori rearrangement products of these Schiff bases undergo further rearrangement and modification, which results in advanced glycation end products (AGE). 3 Glycation has been shown to alter the biological activity of LDL and to result in reduced rate of degradation by fibroblasts 4 and increased cholesteryl ester deposition in human aortic cells compared with normal LDL. 5 Using anti-AGE antibodies, Bucala et al 6 have shown that the lipid moiety of glycated LDL is involved in LDL susceptibility to oxidation, but no products of lipid glycation were identified. Gugliucci et al 7 showed that LDL glycation constitutes a predisposing event to its subsequent oxidative modification and that LDL and VLDL fractions from diabetic patients are more susceptible to oxidation. Furthermore, glycation of LDL has been reported 8 to accelerate LDL oxidation by copper ions, and glycation and lipid oxidation have been reported to increase the uptake of LDL particles by macrophages. 9 In none of these instances were glycated or oxidized lipids isolated or identified nor was a distinction made between effects of protein and lipid glycation. We have recently shown 10, 11 that plasma phosphatidylethanolamine (PtdEtn), which composes 5% to 6% of total phospholipid, can be readily glucosylated and the glucosylation products isolated. The present study demonstrates that glucosylated glycerophosphoethanolamines are the major LDL lipid glycation products. Furthermore, glucosylated (Glc) PtdEtn added to nonglycated LDL promotes the oxidation of phosphatidylcholine (PtdCho) and cholesteryl esters.
Methods

Materials
Egg yolk PtdEtn, bovine brain PtdEtn, 1-palmitoyl-2-linoleoyl glycerophosphoethanolamine (GroPEtn), NaCNBH 3 , and NaBH 4 were obtained from Sigma-Aldrich. A standard mixture of phospholipids made up of equal-weight proportions of PtdCho, PtdEtn, phosphati-dylserine (PtdSer), phosphatidylinositol (PtdIns), lysoPtdCho, and sphingomyelin (SM) was also purchased from Sigma-Aldrich.
D-Glucose-1-[
14 C] was obtained from New England Nuclear. All solvents were of high-performance liquid chromatographic (HPLC) grade or higher quality and were obtained from local suppliers.
Synthesis and Isolation of Glc PtdEtn
Glc PtdEtn was prepared and purified as described in detail previously. 10 Briefly, PtdEtn (2 mg) dissolved in 1 mL of methanol was transferred to a 15-mL test tube and the solvent evaporated under nitrogen. Four mL of 0.1 mol/L phosphate buffer containing 0 to 400 mmol/L glucose and 0.1 mmol/L EDTA were added and sonicated at low power for 5 minutes at room temperature. The mixture was incubated under nitrogen at 37°C for various periods of time. Lipids were extracted into chloroform/methanol (2:1, vol/vol) as described by Folch et al 12 and the solvents evaporated under nitrogen. Some samples were reduced by addition of a methanolic solution of either NaCNBH 3 or NaBH 4 to a final concentration of 70 mmol/L and incubation at 4°C for 1 hour. Reduction products were washed with water, reextracted with chloroform/methanol (2:1, vol/vol), and dried under nitrogen. Samples were redissolved in chloroform/methanol (2:1, vol/vol) and kept at Ϫ20°C until analysis. Glc PtdEtn (2 mg) was purified by preparative thin-layer chromatography (TLC; 20ϫ20-cm glass plates) coated with silica gel H (250-m-thick layer). Chromatoplates were developed with chloroform/methanol/30% ammonia (65:35:7 by volume) as described. 10 Phospholipids were identified by cochromatography with appropriate standards and visualization of any lipid bands under ultraviolet light after the plate was sprayed with 0.05% 2,7-dichlorofluorescein in methanol. Both glucosylated and nonglucosylated lipids were recovered by scraping the gel from appropriate areas of the plate and extracting it twice with the developing solvent.
Liposomal Oxidation
Unilamellar liposomes of egg yolk phospholipids or of the standard phospholipid mix (0.5 mg/mL) were prepared by ethanol injection method 13 in 0.1 mol/L phosphate buffer. Unilamellar liposomes containing 10% Glc egg yolk PtdEtn were prepared similarly. Liposomes in the phosphate buffer, including those supplemented with Glc PtdEtn, were peroxidized by incubation with 10-mmol/L tert-butyl hydroperoxide as the oxidant. At different times, aliquots were withdrawn. Lipids were extracted with chloroform-methanol (2:1 vol/vol) and washed repeatedly with buffer to remove residual tert-butyl hydroperoxide. Samples were analyzed by liquid chromatography with online electrospray mass spectrometry (LC/ESI/MS) immediately after being extracted.
Lipoprotein Isolation
LDL (1.019 to 1.069 g/mL) was obtained by density gradient ultracentrifugation 14 from plasma of fasted normolipidemic individuals. LDL (2 mg protein per milliliter) was subsequently dialyzed against 0.1 mol/L phosphate buffer (pH 7.4) that contained 0.1 mmol/L EDTA for 24 hours (3 buffer changes). LDL samples were sterilized by being passed through a 0.22-m filter (Millipore), stored at 4°C, and used within 1 week. Lipoprotein concentration was determined by the method of Lowry et al 15 and expressed in milligrams per milliliter. Oxidation of LDL (5 mg protein per 5 mL) was performed by dialysis against 5 mol/L CuSO 4 .5 H 2 O in 0.1 mol/L phosphate buffer, pH 7.4, for 24 hours at 37°C in the dark. Lipids were extracted into chloroform/methanol (2:1 vol/vol) as described above.
Enrichment of LDL With PtdEtn
Glc and non-Glc PtdEtn was incorporated into LDL in a manner similar to that described by Engelmann et al 16 for enriching human plasma lipoproteins with phospholipids. Glc PtdEtn (1 mg) in chloroform-methanol (2:1 vol/vol) was transferred to a 15-mL test tube. The solvent was evaporated under nitrogen, and the lipids were dispersed by centrifuging in 1.5 mL buffer that contained 50 mmol/L Tris/HCl, 1 mmol/L DTT, and 0.03 mmol/L EDTA (pH 7.4). Solutions were sonicated in a bath sonicator for 5 minutes at 1-minute intervals while being kept on ice under a stream of nitrogen. The liposome mixture was centrifuged at 3500g, and the supernatant was collected and passed through a 0.45m filter. The liposomal mixture (1 mL) was added to fresh plasma (4 mL) that contained 3 mmol/L NaN 3 , under gentle mixing. The mixture was incubated under nitrogen at 37°C for 24 hours. Lipoproteins were isolated as described above.
LDL Glucosylation
LDL (2 mg protein per milliliter) in PBS that contained 1 mmol/L EDTA, 0.1 mg/mL chloramphenicol, and 3 mmol/L NaN 3 was incubated with 5 to 400 mmol/L glucose at 37°C for 1 week under nitrogen. Other incubation mixtures contained 3 Ci/mL D-glucose-1-14 C. At the end of incubation, LDL samples were extracted with chloroform/methanol (2:1 vol/vol). LDL samples that contained radiolabeled glucose were reduced with NaBH 4 for 1 hour at 4°C and dialyzed against 0.1 mol/L phosphate buffer that contained 0.1 mmol/L EDTA for 24 hours to remove free radioactive glucose. After dialysis was complete, lipids were extracted and radioactivity measured in both protein and lipid fractions.
Extraction of Atherosclerotic Plaques
Atherosclerotic plaques obtained from patients during carotid endarterectomy and from postmortem carotid arteries (24 hours after death) were available from previous studies. 18 Plaques from intermediate to advanced lesions were immediately placed into PBS, pH 7.4, that contained 0.1% EDTA. Plaque material (100 mg) was separated from media and adventitia and minced (0.5 to 1.0 mm 2 pieces), and total lipid extracts were prepared with chloroform/ methanol (2:1 vol/vol). 19 Tissue lipid extracts were stored in chloroform at Ϫ20°C under nitrogen. 
Analysis of Fatty Acid Methyl Esters
LDL lipid classes were isolated by preparative TLC on silica gel H with heptane/isopropyl ether/acetic acid (60:40:4 by volume) as solvent. 20 In this system, phospholipids were retained at origin, whereas free fatty acids, triacylglycerols, and cholesteryl esters were resolved in order of decreasing polarity. Appropriate areas of the plate were cleared of silica gel, and fatty acid methyl esters (FAME) were prepared by treating the gel with 6% H 2 SO 4 in methanol for 2 hours at 80°C. Heptadecanoic acid was included as an internal standard at Ϸ10% of total fatty acid concentration. After reaction, the FAME were extracted twice with hexane. The solvent was blown down under nitrogen and the samples redissolved in hexane. Fatty acids were analyzed on a polar capillary column (SP 2380, 15 mϫ0.32 mm ID, Supelco) installed in a Hewlett Packard model 5880 gas chromatograph equipped with a flame ionization detector. Hydrogen was the carrier gas at 3 PSI. 21 
Analysis of Phospholipid Classes
Normal-phase HPLC of phospholipids was performed on a 3-m Spherisorb column (100ϫ4.6 mm ID) or a longer 5-m Spherisorb column (250ϫ4.6 mm ID; Alltech Associates). Columns were installed into a Hewlett-Packard model 1090 liquid chromatograph and eluted with a linear gradient of 100% solvent A (chloroform/ methanol/30% ammonium hydroxide, 80:19.5:0.5 by volume) to 100% solvent B (chloroform/methanol/water/30% ammonium hydroxide, 60:34:5.5:0.5 by volume) for 14 minutes, then in 100% solvent B for 10 minutes. 10, 22 Flow was set at 1 mL/min. Peaks were monitored by online ESI/MS.
Analysis of Molecular Species of Phospholipids
Normal-phase HPLC with LC/ESI/MS was performed by splitting HPLC flow by 1/50, which resulted in admission of 20 L/mL to a Hewlett-Packard model 5988B quadrupole mass spectrometer equipped with a nebulizer-assisted electrospray interface (HP 59987A). 22 Tuning and calibration of the system was achieved in the mass range of 400 to 1500 atomic mass units (AMU) by using of the standard phospholipid mix dissolved in HPLC solvent A and flow-injected at 50 L/min into the mass spectrometer. Capillary LDL was incubated with 20 mmol/L glucose for 7 days (pH 7.4) at 37°C (nϭ4). Lipids were extracted, and different phospholipid classes were separated by normal-phase silica-column HPLC. Resolved peaks were analyzed by online electrospray ms.
voltage was set at 4 kV, endplate voltage at 3.5 kV, and cylinder voltage at 5 kV in the positive mode of ionization. In the negative mode, voltages were 3.5, 3, and 3.5 kV, respectively. Both positive and negative ion spectra were taken in the mass range 100 to 1100 AMU. Capillary exit (Cap Ex) voltage was set at 120 Vin the positive and 160 V in the negative ion mode. For fragmentation studies, Cap Ex voltage was raised to 300 V. Nitrogen gas was used as both nebulizing gas (40 PSI) and drying gas (60 PSI, 270°C). Phospholipids, including glucosylated diradylglycero phosphoethanolamine, were quantified on the basis of standard curves established for each phospholipid class and for the oxidized phospholipids (core aldehydes, hydroperoxy, and isoprostanes). Oxidized phospholipids that were used as standards were prepared as previously described. 20 The detection limit for Glc PtdEtn with normal scanning range (400 to 1100 AMU) was 20 to 30 pmol, and the response was linear to 100 nmol. Equimolar ion intensities of different species of each phospholipid class varied by Ͻ5% 23 in each of the ion modes. LC/ESI/MS response to different phospholipid classes varied greatly and required regular use of standards. 14 C]. Incubation mixture was reduced with NaBH 4 and dialyzed extensively. Radioactivity was measured by scintillation counting for both lipid and protein fractions and is given as moles of glucose per LDL molecule. Molecular weight of ApoB was assumed to be 500 kDa. 
Measurement of Radioactivity
Radioactivity in glucosylated diradyl GroPEtn and proteins was determined by scintillation counting after lipid extraction and TLC. The silica gel that contained the Glc Etn phospholipids was scraped into scintillation vials with CytoScint (ICN Pharmaceuticals). The radioactivity in the protein precipitate was determined after the precipitate was dissolved in CytoScint.
Results
Isolation of Glc PtdEtn From Glucosylated LDL
Glc PtdEtn may occur in LDL as the Schiff base adduct or its Amadori rearrangement product (Figure 1 ). The glucose adducts of PtdEtn were originally recognized as part of the front of the PtdCho peak detected by conventional normalphase LC/ESI/MS as already described for total plasma and red blood cell extracts of diabetic subjects. 11 By use of longer HPLC columns, a complete resolution was obtained for the PtdCho, PtdIns, and Glc PtdEtn components overlapping on the shorter column. Furthermore, with the use of the negative ion mode, the major PtdCho peak was seen only as minor PtdChoϩCl adduct, which provided a clear view (Figure 2A ) of the Glc diradylGroPEtn peak after incubation of LDL with 50 mmol/L glucose. Figure 2B shows single-ion plots of the major species of both Glc PtdEtn and PlsEtn, which elute with the same retention time as standard Glc PtdEtn. Figure  2C shows the full-mass spectrum averaged over the elution time of the Glc diradyl GroPEtn peak. The spectrum includes many molecular species, which are quantified in Table 1 . Table 1 shows that the glucosylation of the ethanolamine phospholipids of LDL was largely indiscriminate, given that both PtdEtn and alkenylacyl GroPEtn components were glucosylated. However, on average, the diacyl species represent a somewhat higher proportion of total glucosylated ethanolamine phospholipids. The species present in untreated LDL show a decrease in PlsEtn glycation compared with LDL incubated with glucose in vitro. The 2 major species in both in vivo and in vitro glycated LDL were 18:0-18:2 and 18:0-20:4 GroPEtn. The difference in glycosylation in untreated LDL shows that the diacyl species represent the majority of the glycated ethanolamine phospholipids.
Although we investigated the possible presence of other aminophospholipid glycation products, such as glycated PtdSer or carboxymethylPtdEtn, in both untreated LDL and LDL incubated with glucose, we did not detect ions in the chromatogram pertaining to these products. Figure 3 shows the fragment ions obtained for the palmitoyllinoleoylGroPEtn glucosylate in the negative and positive ionization mode as obtained for the HPLC peak eluting at 15.8 minutes. In the negative ion mode ( Figure 3A) , fragmentation of the molecular ion (m/z 876) gave palmitic (m/z 255) and linoleic (m/z 279) acids. The ion at m/z 712 is due to loss of glucose moiety, whereas the ion at m/z 756 results from cleavage of the attached glucose between carbons 2 and 3. In the positive ion mode (Figure 3B) , the ion at m/z 303 represents Glc PEtn and the ion at m/z 576 the diacyl Gro fragment. The ion at m/z 180 was due to cleavage of the adduct with a retention of nitrogen with the glucose moiety. The same fragmentation pattern was observed for Glc PtdEtn present in LDL, with more complex fragmentation patterns due to the presence of multiple species. In both modes of ionization, the fragments produced were consistent with either Schiff base or Amadori rearrangement product of Glc PtdEtn, but the relatively higher stability of the complex suggested the Amadori product, as concluded previously by Lederer et al. 24 
Rate of Glucosylation of LDL
The concentration dependence of LDL lipid glucosylation was investigated by determining the time course of Glc PtdEtn and Glc PlsEtn accumulation in LDL by LC/ESI/MS. Figure 4 shows the concentration dependence of LDL diradylGroPEtn glucosylation. Even at 5 mmol/L glucose (24-hour incubation), 4-nmol/mg LDL protein Glc GroPEtn was present. This represents 8.6% of total LDL diradylGroPEtn (52 nmol/mg LDL protein) in glucosylated form at physiological glucose concentrations. These levels were close to the amounts found in untreated LDL (3.2 nmol/mg LDL protein), indicative of in vivo levels of PtdEtn glycation. The level of Glc diradylGroPEtn in LDL incubated at 400 mmol/L glucose for 7 days at 35 nmol/mg LDL protein represents 67% of total LDL diradylGroPEtn being glucosylated. Even at these high glucose concentrations, glycation of LDL diradylGroPEtn was incomplete. With radiolabeled glucose, the differences between the rate of lipid and protein glycation in LDL were investigated. Figure 5 shows that the initial rate of incorporation of radioactivity was significantly higher in the lipid than protein fraction. A TLC examination of the lipid phase indicated that Ϸ92% of the radioactivity in the lipid pool was recovered in the band that corresponded to the NaBH 4 reduction product of Glc diradylGroPEtn, and further analysis by LC/ESI/MS gave the correct molecular weights for the reduced Glc diradylGroPEtn products (data not shown). This demonstrates that Glc diradylPEtn is the initial and major LDL glucosylation product.
Relative Rates of Oxidation of PtdEtn and Glc PtdEtn
The effect of glycation on PtdEtn oxidation was determined by comparing the rates of tert-butyl hydroperoxidation of glucosylated and non-Glc PtdEtn incorporated at 10% mass into unilamellar egg yolk PtdCho liposomes ( Figure 6 ). Figure 6A shows the time course of hydroperoxidation of 18:0-18:2 GroPEtn and glucosylated 16:0-18:2 GroPEtn when incorporated into PtdCho liposomes, as determined by LC/ESI/MS. Monohydroperoxides were the major oxidized molecules monitored in both PtdEtn molecules. Glc PtdEtn is noted to be peroxidized 2 to 3 times more readily than non-Glc PtdEtn. Furthermore, Glc PtdEtn displayed prooxidant activity toward non-Glc PtdEtn and PtdCho. Figure 6B shows that 16:0 to 20:4 and 16:0 to 18:2 GroPCho liposomes in presence of Glc PtdEtn were peroxidized at a 2 to 3 times higher rate than the same PtdCho liposomes supplemented with non-Glc PtdEtn.
Pro-oxidant Activity of Glc PtdEtn in LDL
To investigate further the apparent pro-oxidant effect of Glc Etn phospholipids, we measured the peroxidation of LDL by copper ions in the presence and absence of added glucosylated 16:0-18:2 GroPEtn (10 to 30 nmol/mg LDL protein). This amount corresponds to levels obtained for LDL incubation with 50 mmol/L for 48 hours. Control LDL contained 10 to 20 nmol/mg LDL protein of added nonglucosylated 16:0-18:2 GroPEtn. Extent of lipid peroxidation was determined by measuring the hydroperoxides and core aldehydes of the most abundant PtdCho species of the 2 LDL preparations. Figure 7 compares the phospholipid profiles of untreated LDL ( Figure  7A ) and copper-oxidized LDL plus PtdEtn (12 hours, 37°C) ( Figure 7B ) and copper-oxidized LDLϩGlc PtdEtn (12 hours, 37°C) ( Figure 7C ) as obtained by positive-ion LC/ESI/MS. Figure 7A shows the resolution of the PtdCho, SM, and lysoPtdCho, which are the major phospholipid components of native LDL. The PtdCho, SM, and lysoPtdCho peaks are split because of a resolution of the short and long carbon-chain species. After copper-ion oxidation ( Figure 7B ), a dramatic change occurs in the composition of the LDL phospholipids, largely as a result of conversion of the unsaturated PtdCho into the hydroperoxides, core aldehydes, and isoprostanes, which are eluted later than the saturated PtdCho species. In addition, a relative increase has occurred in the proportion of lysoPtdCho, possibly as a result of hydrolysis of the peroxidized PtdCho by the phospholipases present in LDL. After supplementation of the LDL with Glc PtdEtn (Figure 7C ), a 4-to 5-fold increase occurs in the lipid peroxidation. The absolute amount of LDL SM remained unchanged in both PtdEtn-supplemented (27.9% total phospholipid) and Glc PtdEtn-supplemented LDL preparations (26.7%), although this is not immediately obvious from either Figure 7B or 7C. Figure 8A shows the full-mass spectrum averaged over the range of elution times of the hydroperoxy PtdCho (17.070 to 18.603 minutes), whereas Figure 8B shows the single-ion plots corresponding to the monohydroperoxy, dihydroperoxy and isoprostane derivatives of the major PtdCho species. The arachidonate-containing species (16:0-20:4 GroPCho) with 2 hydroperoxy groups (2xOOH) are resolved into 3 subfractions presumably due to the presence of positional and cis, trans isomers of the hydroperoxides. Figure 9 shows the time course of PtdCho hydroperoxide formation during dialysis against copper ions of LDL supplemented with Glc PtdEtn or PtdEtn. The major PtdCho hydroperoxides, 34:2 1xOOH (m/z 790), 36:2 1xOOH (m/z 818), 34:2 2xOOH (m/z 822), and 36:4 2xOOH (m/z 846), are all increased significantly in Glc PtdEtn supplemented LDL, with 34:2 1xOOH the most abundant. LC/ESI/MS analysis of the NaBH 4 reduced peroxidation products indicated that the hydroperoxy PtdCho had been converted into the corresponding hydroxy PtdCho. Addition of Glc PtdEtn to LDL resulted in about 5-fold increase in the formation of phospholipid-bound hydroperoxides as calculated from averaged differences from all time points. Figure 10A shows the full-mass spectrum averaged over the elution range (18.76 to 19.19 minutes) , of the C 9 core aldehydes of PtdCho, which are eluted ahead of the C 5 core aldehydes. Figure 10B shows the full spectrum averaged over the entire range (20.78 to 21.39 minutes) of the C 5 aldehydes which trail into the SM species (m/z 675, palmitoyl sphingosinephosphocholine). Figure 10C shows the single-ion plots for all 4 major molecular species of the PtdCho core aldehydes. The 9-oxononanonates and 5-oxo-valerates of the palmitoyl and stearoyl GroPCho represented the major components expected on the basis of the fatty acid composition of the molecular species of LDL PtdCho. Figure 11 shows the time course of PtdCho core aldehyde formation during copper oxidation of LDL supplemented with Glc PtdEtn or PtdEtn. Major core aldehydes are the 16:0-9:0 Ald and the 18:0-9:0 Ald species, as expected from presence of linoleic acid as the major unsaturated fatty acid (61%) in the sn-2 position of LDL PtdCho. NaBH 4 treatment resulted in a reduction of the aldehydes to the corresponding alcohols, as reflected in the increase of 2 AMU in the molecular ion of each PtdCho core aldehyde (data not Figure 10 . Major PtdCho core aldehydes in oxidized LDL supplemented with Glc PtdEtn. A, Spectra averaged over the earlyeluting (C 9 aldehydes in sn-2) and late-eluting (C 5 aldehydes in sn-2) aldehyde peaks. B, Single-ion plots of the C 9 and C 5 PtdCho core aldehydes. LC/ESI/MS and oxidation conditions are as described in Figure 2. shown). On average, the increase in core aldehyde formation as a result of Glc PtdEtn supplementation was Ϸ4-fold.
Addition of Glc PtdEtn to LDL also promoted oxidation of cholesteryl esters in the interior of the particle. Figure 12 shows a more rapid loss of the 2 major species of polyunsaturated cholesteryl esters during dialysis against copper ions of LDL supplemented with Glc PtdEtn when compared with LDL supplemented with similar amounts of PtdEtn. Destruction of the arachidonoyl ester occurred at a much faster rate than that of the linoleoyl ester of cholesterol. Furthermore, the cholesteryl esters appeared to undergo peroxidation much more rapidly than the glycerophospholipids (compare Figures 10 and 12) , which suggests that access to the interior of the particle was facilitated by addition of Glc PtdEtn. Figure 13 shows the total negative ion current profile ( Figure  13A ), the single-ion chromatograms for major species ( Figure  13B) , and the mass spectrum averaged over the elution time (15.01 to 15.89 minutes) of the glycated ethanolamine phospholipid peak ( Figure 13C) , as obtained by normal-phase LC/ESI/MS for a total lipid extract of an atherosclerotic plaque from a diabetic man. To increase the sensitivity of detection, scanning was limited to a mass range of 850 to 1000 AMU, which eliminated any overlap with the PtdEtn, PtdChoϩCl, and SMϩCl ions also present in the total negative LC/ESI/MS profile. As a result, only the dimers of the molecular species of lysoPtdCho remained visible. Table  2 compares the composition of the molecular species of glycated and nonglycated ethanolamine phospholipids isolated from the atheroma. Considerable discrepancy exists between the glycated and nonglycated sets of species, which excludes direct in situ interconversion and suggests possible deposition of these lipids from the circulation. Composition of the molecular species of the ethanolamine phospholipids of the atheroma also differs significantly from that of human LDL (Table 1) , with the relative proportion of the polyunsaturated PtdEtn and specially PlsEtn species being reduced. The most abundant glycated PlsEtn species in the plaque was 38:4 (m/z 928). The possibility of selective glycation or oxidation is indicated by the absence of glycated PtdSer species, although PtdSer species were detected in the atheroma. In samples analyzed from nondiabetic individuals, we found 2.4-nmol glycated diradylGroPEtn per milligram total lipid, which represented 1.3% of the total atheroma phospholipid. The atherosclerotic tissue from diabetics contained 11.5-nmol glycated diradylGroPEtn per milligram total lipid, which represented 7.3% of total atheroma phospholipid, whereas an analysis of normal aortic tissue did not show any PtdEtn glycation. These results are comparable to levels of glycated PtdEtn previously measured by our group in plasma of diabetic individuals (4.8% glycated GroPEtn per milligram total phospholipid). 11
Isolation of Glc PtdEtn and PlsEtn From Atherosclerotic Tissue
Discussion
LDL oxidation is claimed to play a central role in atherogenesis, which is exacerbated in diabetic hyperglycemia. 1 Hyperglycemia is known to promote LDL glycation 6, 17 and lipid peroxidation, 6, 25 but the relative importance of protein and aminophospholipid glycation in these processes has not been established. Using previously prepared standards of Glc PtdEtn, 10 we have now identified the lipid glycation product of LDL as a mixture of glycated diacyl and alkenylacylGro- 
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PEtn. We had previously shown 10, 11 that the glucose adduct of PtdEtn possesses a molecular weight that corresponds to either the Schiff base or its Amadori rearrangement product.
In the present study, we have examined the glucosyl PtdEtn isolated from Glc LDL by pseudo-MS/MS with electrospray 23 and have obtained fragment ions, which are consistent with both Schiff base and its Amadori rearrangement product. On the basis of the relatively high stability of the adduct, we must conclude that the structure is more likely to be that of the Amadori product rather than of the simple Schiff base. This conclusion is consistent with the recent report of Lederer et al, 24 who have unequivocally proven that Amadori products are formed from D-glucose and PtdEtn in an in vitro model system. Furthermore, Requena et al 26 have recently demonstrated the formation of carboxymethylEtn after hydrolysis of the aminophospholipid adduct. Bucala et al 6, 25 had shown in vitro that glycation of PtdEtn results in the formation of immunochemically detectable AGE. Furthermore, using ELISA, these authors concluded that the bulk of the AGE in LDL isolated from normal and diabetic subjects was located in the lipid phase. 27 Pamplona et al 28 had obtained evidence for glycated aminophospholipids in rat liver and for their increase in animals with streptozotocin-induced diabetes. With Amadori-product formation from glucose and PtdEtn now clearly established, we undertook further investigations on the effect of Glc PtdEtn on LDL lipid oxidation.
Of special interest to LDL lipid oxidation was the presence of the PlsEtn and its fate during glycation. Previous work had attributed both antioxidant 29 and pro-oxidant 30 properties to PlsEtn in various biological systems, although the effect of PlsEtn on LDL oxidation had not been directly studied. Myher et al 31 showed that of the total diradylGroPEtn of plasma, 71.8% was due to alkenylacyl, 19.9% to diacyl, and 8.3% to alkylacyl species. The bulk of these phospholipids were assumed to originate in plasma LDL. The LDL preparation used in the present studies contained 49.4% PlsEtn, whereas glucosylated LDL contained 35% PlsEtn of total diradylGroPEtn. Thus, only 70% of the LDL PlsEtn was glucosylated under the present working conditions. Furthermore, the glucosylated species of both PtdEtn and PlsEtn tended to be more saturated than the respective nonglucosylated species. Analysis of diabetic plasma and red blood cells for glycated diradylGroPEtn in our earlier study 11 had indicated a near absence of glycated PlsEtn species, whereas aminophospholipids isolated from red blood cells and plasma were glucosylated in vitro in proportion to their masses. Other studies 5 have shown that hyperglycemic individuals have a significantly lower PtdEtn in LDL compared with normoglycemic controls, but it has not been established whether this is Figure 12 . Loss of polyunsaturated cholesteryl esters during coppercatalyzed oxidation of LDL in presence of Glc PtdEtn. A, Cholesteryl linoleate; B, cholesteryl arachidonate. Cholesterol FAME were analyzed by gas-liquid chromatography as described in Methods. Figure 13 . Identification of glycated diradylGroPEtn from atherosclerotic tissue of a diabetic male. A, Total negative ion profile (mass range, 850 to 1000 AMU). B, single ion plots for the major glycated PtdEtn and PlsEtn species. C, Averaged spectra from the glycated diradylGroPEtn peak (15.01 to 15.89 minutes). LC/ESI/MS is as described in Figure 2. due to decreased PlsEtn. The loss of alkenylacyl species from glycated ethanolamine phospholipids could be due to their greater susceptibility to peroxidation, 29, 30 given that it has been demonstrated that the vinyl ether bond of alkenylacylGroPEtn is highly sensitive to peroxidation and can act as an antioxidant in protection of other phospholipids. 32 Our study shows a more rapid and more extensive glucosylation of PtdEtn compared with apoprotein B in LDL. The distribution of radioactive glucose suggests that PtdEtn is more susceptible to glucosylation than apoB possibly due to more favorable environment for trapping the initial Schiff base adduct in the lipid phase. Our measurements of radioactive glucose distribution are consistent with the results of Bucala et al, 25 who showed markedly increased levels of AGE in lipid compared with the aqueous (apoprotein) phase in diabetic and end-stage renal disease patients.
The present study shows that Glc PtdEtn is more easily peroxidized than PtdEtn, and that Glc PtdEtn, included in a liposomal mixture, promotes the oxidation of PtdEtn and PtdCho. Oxidation of phospholipids proceeds by way of hydroperoxides to the core aldehydes, all of which were isolated and identified as products of LDL oxidation. Likewise, addition of Glc PtdEtn to LDL caused more extensive oxidation of PtdEtn and PtdCho than addition of an equal amount of PtdEtn. This oxidation took place in the absence of protein glycation and free glucose in the incubation medium. The increased peroxidation of glucosylated ethanolamine phospholipids can probably be attributed to an increased exposure of these molecules to the oxidizing agent when incorporated into a liposome along with other phospholipids. The increased bulk of the polar-head group in the glucosylated aminophospholipid might permit a more ready access of the oxidizing agent to the unsaturated fatty chains of all glycerophospholipids in the liposomes and in the lipid monolayer of LDL. Furthermore, addition of Glc PtdEtn to LDL in absence of protein glycation resulted in increased oxidation of cholesteryl esters, which are located in the interior of the LDL particle. Clearly, Glc PtdEtn or its oxidation in the LDL lipid monolayer facilitates the access of free radicals to the cholesteryl esters in the interior of the LDL particle, which leads to a rapid destruction of the polyunsaturated cholesteryl esters. Previously it has been reported that LDL molecules from diabetic individuals show increased phospholipid layer fluidity, which could explain the increased susceptibility to oxidation. 33 In the past glucose, has been claimed 34 to possess pro-oxidant activity in both free and bound form, but more recently, increasing evidence has been obtained favoring the bound glucose pathway of oxidation of biological macromolecules. On the basis of albumin as a model protein, Hunt et al 35 have concluded that oxidative alterations in experimental diabetes mellitus are due to protein-glucose adduct oxidation. The promotion of LDL lipid peroxidation by Glc PtdEtn demonstrated in the present study would also be consistent with pro-oxidant action of bound glucose. However, direct measurements of the oxidation potential of aminophospholipid-bound glucose in the absence of protein glucosylation suggest that the role of lipid glycation may have been overlooked. Hunt et al 35 did not examine the effect of PtdEtn glycation in their study. In any event, the interplay between glycation, glycoxidation, and lipid peroxidation may be more complex than revealed by model studies, and the separate contributions of each step of the overall process to the final result have yet to be determined. Thus, complications may arise from the interaction of the oxidation products (hydroperoxides and core aldehydes) with free amino groups of both proteins and aminophospholipids as shown elsewhere. 23 Greenspan et al 36 have demonstrated that LDL associated with negatively charged phospholipids causes a dramatic increase in uptake and deposition of cholesteryl esters in J774 macrophages. We have recently shown that the glycation of PtdEtn not only results in increased negative charge but also promotes cholesteryl ester and triglyceride accumulation in macrophages. 37 Extensive data have been reported on the involvement of protein AGE 38 -40 and lipid peroxidation in atheroma development. 39 The identification of glycated PtdEtn and PlsEtn in atheroma suggests that glycated phospholipids may also be involved in plaque formation. The presence of PtdCho core aldehydes is of special interest beause these compounds are found in oxidized LDL 41 and in atherosclerotic tissue. 42 PtdCho core aldehydes have been specifically shown to induce increased monocyte-endothelial interactions in vitro, 41 and PtdCho with a short chain aldehyde in the sn-2 position can mimic plateletactivating factor. 43, 44 In conclusion, the present study demonstrates that Glc PtdEtn is an early product of LDL glucosylation and that it is more readily peroxidized than PtdEtn. Furthermore, Glc PtdEtn pro- motes the peroxidation of LDL phospholipids and cholesteryl esters when included at a level of 10% of total diradylGroPEtn of LDL. These studies lend experimental support to previous speculation about the role of aminophospholipid glycation in LDL oxidation. This is the first report of isolation and identification of glucosylated diradylGroPEtn from LDL and human atherosclerotic tissue. The present study provides evidence that Glc PtdEtn may promote oxidation of LDL phospholipids and cholesteryl esters in hyperglycemia.
